In clinical studies, up to 30 percent of people with macular edema who were given Ozurdex had an improvement in vision of three or more lines on the eye chart two months after receiving the injection, compared with up to 12 percent of people given a placebo (fake injections with no active ingredient). People given Ozurdex had a faster improvement in vision on average than those given the fake injections.
In clinical studies of uveitis, 43 percent of people given Ozurdex had a vision improvement of three or more lines on the eye chart eight weeks after the injection, compared with 7 percent of people given the placebo injections. In addition, 47 percent of the Ozurdex-treated group were considered free from inflammation after eight weeks, compared to 12 percent of those in the placebo group.
Some general considerations to keep in mind during treatment with Ozurdex include the following:
- Ozurdex comes as an implant that is injected into the vitreous humor inside the eye (this is called an intravitreal injection).
- The implant dissolves inside the eye and does not need to be removed.
- A healthcare provider will administer the injection.
- Your healthcare provider will monitor you closely in the days following your procedure. It is important to keep all your follow-up appointments.
- For Ozurdex to work properly, it must be used as prescribed.
There is only one standard dosage of Ozurdex, regardless of your age or the condition being treated (click Ozurdex Dosage for more information).